AmVac begins Phase III trial of Gynevac vaccine for bacterial vaginosis

AmVac has commenced a Phase III study of its Gynevac to assess the safety and efficacy of the vaccine in bacterial vaginosis (BV) treatment.

Image may be NSFW.
Clik here to view.

Manufactured in accordance with the current GMP standards, the therapeutic vaccine is based on a blend of inactivated lactobacilli strains.

http://www.marketwatch.com/story/amvac-initiates-phase-iii-trial-with-its-lead-vaccine-gynevac-for-the-treatment-of-bacterial-vaginosis-2014-06-17

Image may be NSFW.
Clik here to view.

Image may be NSFW.
Clik here to view.

Image may be NSFW.
Clik here to view.